{"id":1011055,"date":"2026-10-16T16:00:07","date_gmt":"2026-10-16T20:00:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/"},"modified":"2026-10-16T16:00:07","modified_gmt":"2026-10-16T20:00:07","slug":"fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/","title":{"rendered":"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes"},"content":{"rendered":"<p>        <!--.bwlistdecimal { list-style-type: decimal }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><b>One drop works to significantly reduce redness, with results lasting up to 12 hours<sup>1<\/sup><\/b><\/li>\n<li><b>Lasts up to 50% longer than Lumify<sup>1-2,*<\/sup><\/b><\/li>\n<li><b>Expands Alcon&#8217;s portfolio of consumer eye care solutions and will be available in major retailers nationwide and online in the coming months<\/b><\/li>\n<\/ul>\n<p>GENEVA&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nAlcon (SIX\/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that the U.S. Food and Drug Administration (FDA) has approved BRYTLY<sup>\u00ae<\/sup> Redness Reliever Eye Drops. With one drop, BRYTLY works in just one minute to significantly reduce redness and delivers up to 12 hours of whiter, brighter-looking eyes.<sup>1<\/sup> Additionally, BRYTLY lasts up to 50% longer than Lumify.<sup>1-2,*<\/sup> The approval brings a differentiated new option to the over the counter (OTC) redness-relief category and expands Alcon\u2019s portfolio of trusted consumer eye care products.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20261016454136\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20261016454136\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 393px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20261016454136\/en\/2937042\/4\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg\" alt=\"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops\" \/><\/p>\n<p style=\"font-size:85%\">FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops<\/p>\n<\/div>\n<p>\nBeauty and wellness routines are increasingly converging, with consumers looking for products that combine visible results, clinical validation and everyday convenience. Research has also found that visible eye redness can influence perceptions of healthiness and attractiveness, creating new relevance for the eyes as part of an overall appearance and wellness routine.<sup>3<\/sup> BRYTLY brings a clinically proven option to this evolving space, by reducing redness and helping eyes look whiter and brighter with results that can last throughout the day, up to 12 hours.<\/p>\n<p>\n\u201cConsumers invest in products that help them look and feel their best, and the appearance of their eyes can be an important part of that,\u201d said Jonathan Balch, General Manager, Ocular Health &amp; Pharmaceuticals, Alcon. \u201cThis FDA approval marks an exciting milestone for Alcon. With BRYTLY, we\u2019re bringing Alcon\u2019s trusted eye care expertise to consumers who want to reduce eye redness and want their eyes to look whiter and brighter. BRYTLY is designed to deliver simple, long-lasting redness reduction that can help consumers feel confident in how their eyes look throughout the day.\u201d<\/p>\n<p>\nBRYTLY contains no bleaches or dyes and is clinically proven to be safe and effective when used as directed.<sup>1<\/sup> Studies also demonstrated a low risk of redness rebound and tachyphylaxis when used as directed.<sup>4-5<\/sup><\/p>\n<p>\n\u201cWhen patients ask about eye whiteners, they want a product they can trust to work effectively and fit into their day,\u201d said Selina McGee<sup>**<\/sup>, founder and chief optometrist of Bespoke Vision in Edmond, Oklahoma. \u201cBRYTLY gives Eye Care Professionals a clinically proven option to recommend, with demonstrated safety and efficacy and long-lasting redness reduction from a single drop.\u201d<\/p>\n<p>\nBRYTLY is expected to be available at major retailers nationwide and online in the coming months, and in additional markets in the future.<\/p>\n<p><b><span class=\"bwuline\">About Alcon<\/span><\/b><\/p>\n<p>\nAlcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people\u2019s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries and territories each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alcon.com%2F&amp;esheet=54623551&amp;newsitemid=20261016454136&amp;lan=en-US&amp;anchor=www.alcon.com&amp;index=1&amp;md5=1868be09a9aba590688c6f926f4ed054\">www.alcon.com<\/a>.<\/p>\n<p><i>*Based on label claim, BRYTLY up to 12 hours \/ Lumify up to 8 hours.<br \/>\n<br \/><\/i><i>**Paid Alcon consultant.<\/i><\/p>\n<p><b><span class=\"bwuline\">References<\/span><\/b><\/p>\n<ol class=\"bwlistdecimal\">\n<li>\nAlcon- BRYTLY Label, 2026.<\/p>\n<\/li>\n<li>\nBAUSCH + LOMB Lumify Label. DailyMed. Published 2025. Accessed February 19, 2026. <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnam12.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fdailymed.nlm.nih.gov%252Fdailymed%252FdrugInfo.cfm%253Fsetid%253D022de945-0b26-40ae-8e88-d3fe2464d106%26data%3D05%257C02%257Cmargaret.cavanaugh%2540edelman.com%257C16e147c402684a940bf308df247b085c%257Cb824bfb3918e43c2bb1cdcc1ba40a82b%257C0%257C0%257C639269782984930741%257CUnknown%257CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%253D%253D%257C0%257C%257C%257C%26sdata%3DEIdW18DENW8STtanbFaZIBE7GCYSzf4SMCwdvj0Wx3E%253D%26reserved%3D0&amp;esheet=54623551&amp;newsitemid=20261016454136&amp;lan=en-US&amp;anchor=https%3A%2F%2Fdailymed.nlm.nih.gov%2Fdailymed%2FdrugInfo.cfm%3Fsetid%3D022de945-0b26-40ae-8e88-d3fe2464d106&amp;index=2&amp;md5=0c6c58cb982897bd8e578aa75ca8ee32\">https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=022de945-0b26-40ae-8e88-d3fe2464d106<\/a>.<\/p>\n<\/li>\n<li>\nProvine RR, Cabrera MO, Nave-Blodgett J. Red, yellow, and super-white sclera: uniquely human cues for healthiness, attractiveness, and age. <i>Human Nature<\/i>. 2013;24:126\u2013136. doi:10.1007\/s12110-013-9168-x.<\/p>\n<\/li>\n<li>\nAlcon data on file, 2025; REF-27135.<\/p>\n<\/li>\n<li>\nAlcon data on file, 2025; REF-27136.<\/p>\n<\/li>\n<\/ol>\n<p><b>Connect with us on<\/b><\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FAlconEyeCare%2F&amp;esheet=54623551&amp;newsitemid=20261016454136&amp;lan=en-US&amp;anchor=Facebook&amp;index=3&amp;md5=7d4aec2316f9b1dd8347ce1837199dca\">Facebook<br \/>\n<\/a><br \/><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Falcon&amp;esheet=54623551&amp;newsitemid=20261016454136&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=e5075df02c0768f882516c710d9b89d0\">LinkedIn<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261016454136r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20261016454136\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20261016454136\/en\/<\/a><\/span><\/p>\n<p><b><span class=\"bwuline\">Investor Relations<br \/>\n<\/span><\/b><br \/>Dan Cravens, Richard Bourne<br \/>\n<br \/>+ 41 589 112 110 (Geneva)<br \/>\n<br \/>+ 1 817 615 2789 (Fort Worth)<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investor.relations@alcon.com\">investor.relations@alcon.com<\/a><\/p>\n<p><b><span class=\"bwuline\">Media Relations<br \/>\n<\/span><\/b><br \/>Steven Smith<br \/>\n<br \/>+ 41 589 112 111 (Geneva)<br \/>\n<br \/>+ 1 817 551 8057 (Fort Worth)<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:globalmedia.relations@alcon.com\">globalmedia.relations@alcon.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Texas Europe Switzerland United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health FDA Other Health General Health Pharmaceutical Optical<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20261016454136\/en\/2937042\/3\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20261016454136\/en\/717676\/3\/Alcon_CMYK_Tag.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes One drop works to significantly reduce redness, with results lasting up to 12 hours1 Lasts up to 50% longer than Lumify1-2,* Expands Alcon&#8217;s portfolio of consumer eye care solutions and will be available in major retailers nationwide and online in the coming months GENEVA&#8211;(BUSINESS WIRE)&#8211; Alcon (SIX\/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that the U.S. Food and Drug Administration (FDA) has approved BRYTLY\u00ae Redness Reliever Eye Drops. With one drop, BRYTLY works in just one minute to significantly reduce redness and delivers up to 12 hours of whiter, brighter-looking eyes.1 Additionally, BRYTLY lasts &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1011055","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes One drop works to significantly reduce redness, with results lasting up to 12 hours1 Lasts up to 50% longer than Lumify1-2,* Expands Alcon&#8217;s portfolio of consumer eye care solutions and will be available in major retailers nationwide and online in the coming months GENEVA&#8211;(BUSINESS WIRE)&#8211; Alcon (SIX\/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that the U.S. Food and Drug Administration (FDA) has approved BRYTLY\u00ae Redness Reliever Eye Drops. With one drop, BRYTLY works in just one minute to significantly reduce redness and delivers up to 12 hours of whiter, brighter-looking eyes.1 Additionally, BRYTLY lasts &hellip; Continue reading &quot;FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-16T20:00:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20261016454136\/en\/2937042\/4\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes\",\"datePublished\":\"2026-10-16T20:00:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/\"},\"wordCount\":745,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261016454136\\\/en\\\/2937042\\\/4\\\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/\",\"name\":\"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261016454136\\\/en\\\/2937042\\\/4\\\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg\",\"datePublished\":\"2026-10-16T20:00:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261016454136\\\/en\\\/2937042\\\/4\\\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20261016454136\\\/en\\\/2937042\\\/4\\\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/","og_locale":"en_US","og_type":"article","og_title":"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes - Market Newsdesk","og_description":"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes One drop works to significantly reduce redness, with results lasting up to 12 hours1 Lasts up to 50% longer than Lumify1-2,* Expands Alcon&#8217;s portfolio of consumer eye care solutions and will be available in major retailers nationwide and online in the coming months GENEVA&#8211;(BUSINESS WIRE)&#8211; Alcon (SIX\/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that the U.S. Food and Drug Administration (FDA) has approved BRYTLY\u00ae Redness Reliever Eye Drops. With one drop, BRYTLY works in just one minute to significantly reduce redness and delivers up to 12 hours of whiter, brighter-looking eyes.1 Additionally, BRYTLY lasts &hellip; Continue reading \"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-16T20:00:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20261016454136\/en\/2937042\/4\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes","datePublished":"2026-10-16T20:00:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/"},"wordCount":745,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20261016454136\/en\/2937042\/4\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/","name":"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20261016454136\/en\/2937042\/4\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg","datePublished":"2026-10-16T20:00:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20261016454136\/en\/2937042\/4\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20261016454136\/en\/2937042\/4\/FDA_Approves_Alcons_BRYTLY_Redness_Reliever_Eye_Drops_for_Up_to_12_Hours_of_Whiter_Brighter-Looking_Eyes.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fda-approves-alcons-brytly-redness-reliever-eye-drops-for-up-to-12-hours-of-whiter-brighter-looking-eyes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FDA Approves Alcon\u2019s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1011055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1011055"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1011055\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1011055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1011055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1011055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}